Brainstorm cell therapeutics to announce first quarter results and provide a corporate update on may 15, 2025

New york , may 7, 2025 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will hold a conference call to update shareholders on financial results for the first quarter ended march 31, 2025, and provide a corporate update, at 8:30 a.m. eastern time on thursday, may 15, 2025.
BCLI Ratings Summary
BCLI Quant Ranking